WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a fiscal fourth-quarter loss of $29.3 million, after reporting a profit in the same period a year earlier.

The Watertown, Massachusetts-based company said it had a loss of $1.46 per share. Losses, adjusted for pretax expenses, were 55 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share.

The biotechnology company posted revenue of $23.6 million in the period, missing Street forecasts. Five analysts surveyed by Zacks expected $25.6 million.

For the year, the company reported a loss of $36.2 million, or $1.81 per share, swinging to a loss in the period. Revenue was reported as $122.5 million.

Enanta Pharmaceuticals shares have dropped 29% since the beginning of the year. In the final minutes of trading on Monday, shares hit $43.67, a decrease of 31% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA

© 2020 The Canadian Press. All rights reserved., source Canadian Press DataFile